HMG, or human menopausal gonadotropin, is a purified fertility medication essential in assisted reproductive technology (ART). Sourced from postmenopausal women, HMG contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH), promoting ovarian follicle development and egg production in patients needing both hormonal components. This unique combination offers advantages over recombinant FSH, which lacks LH, making HMG particularly effective for ovarian stimulation. Clinical studies highlight HMG’s role in ART, with data often showing no significant difference in birth rates compared to r-hFSH. Additionally, HMG’s glycosylation pattern adds unique bioactivity, potentially influencing its effectiveness based on patient factors such as age and ovarian reserve.
Bühler, K.F., Fischer, R., Verpillat, P., Allignol, A., Guedes, S., Boutmy, E., Bilger, W., Richter, E., and D’Hooghe, T., 2021. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (HMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany. Reproductive Biology and Endocrinology.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about EURO-HMG by Euro-Pharmacies, consult with your doctor or healthcare professional.
Bühler, K.F., Fischer, R., Verpillat, P., Allignol, A., Guedes, S., Boutmy, E., Bilger, W., Richter, E., and D’Hooghe, T., 2021. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (HMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany. Reproductive Biology and Endocrinology.
Bühler, K.F., Fischer, R., Verpillat, P., Allignol, A., Guedes, S., Boutmy, E., Bilger, W., Richter, E., and D’Hooghe, T., 2021. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (HMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany. Reproductive Biology and Endocrinology.
Bühler, K.F., Fischer, R., Verpillat, P., Allignol, A., Guedes, S., Boutmy, E., Bilger, W., Richter, E., and D’Hooghe, T., 2021. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (HMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany. Reproductive Biology and Endocrinology.
Home
